T. Rowe Price Investment Management, Inc. Pacific Biosciences Of California, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $164 Billion
- Q3 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 217 shares of PACB stock, worth $349. This represents 0.0% of its overall portfolio holdings.
Number of Shares
217
Previous 7,299
97.03%
Holding current value
$349
Previous $10,000
90.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PACB
# of Institutions
245Shares Held
190MCall Options Held
1.27MPut Options Held
601K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl30.9MShares$49.8 Million0.28% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$38 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$32.9 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.4MShares$26.4 Million0.0% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V810.7MShares$17.2 Million0.21% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $362M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...